Evolus, Inc.
Evolus, Inc. (0K16.L) Financial Performance & Income Statement Overview
Review Evolus, Inc. (0K16.L) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Evolus, Inc. (0K16.L) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Evolus, Inc. 0K16.L financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $68.70M | $68.07M | $78.95M | $61.09M |
| Cost of Revenue | $23.38M | $21.42M | $28.60M | $18.22M |
| Gross Profit | $45.32M | $46.66M | $50.34M | $42.86M |
| Gross Profit Ratio | $0.66 | $0.69 | $0.64 | $0.70 |
| R&D Expenses | $1.84M | $2.21M | $2.43M | $2.31M |
| SG&A Expenses | $56.67M | $56.64M | $50.24M | $52.51M |
| Operating Expenses | $58.51M | $58.85M | $52.66M | $58.34M |
| Total Costs & Expenses | $81.89M | $80.27M | $81.26M | $76.56M |
| Interest Income | $479000.00 | $710000.00 | $789000.00 | $928000.00 |
| Interest Expense | -$7.21M | $4.42M | $4.57M | $4.76M |
| Depreciation & Amortization | $932000.00 | $1.83M | $1.61M | $1.09M |
| EBITDA | -$23.47M | -$12.58M | -$3.12M | -$13.001M |
| EBITDA Ratio | -$0.34 | -$0.18 | -$0.04 | -$0.21 |
| Operating Income | -$10.21M | -$15.17M | -$2.31M | -$15.47M |
| Operating Income Ratio | -$0.15 | -$0.22 | -$0.03 | -$0.25 |
| Other Income/Expenses (Net) | -$6.88M | -$3.65M | -$4.04M | -$3.56M |
| Income Before Tax | -$17.09M | -$18.82M | -$6.35M | -$19.04M |
| Income Before Tax Ratio | -$0.25 | -$0.28 | -$0.08 | -$0.31 |
| Income Tax Expense | -$53000.00 | $72000.00 | $440000.00 | $134000.00 |
| Net Income | -$17.14M | -$18.89M | -$6.79M | -$19.17M |
| Net Income Ratio | -$0.25 | -$0.28 | -$0.09 | -$0.31 |
| EPS | -$0.27 | -$0.30 | -$0.11 | -$0.30 |
| Diluted EPS | -$0.27 | -$0.30 | -$0.11 | -$0.30 |
| Weighted Avg Shares Outstanding | $64.54M | $63.70M | $61.74M | $63.15M |
| Weighted Avg Shares Outstanding (Diluted) | $64.54M | $63.70M | $63.37M | $63.15M |
Over the past four quarters, Evolus, Inc. demonstrated steady revenue growth, increasing from $61.09M in Q3 2024 to $68.70M in Q2 2025. Operating income reached -$10.21M in Q2 2025, maintaining a consistent -15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$23.47M, reflecting operational efficiency. Net income rose to -$17.14M, with EPS at -$0.27. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan